Abivax raises €46.2m for product development
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
EquityABBs-Block Trades

Abivax raises €46.2m for product development

Aidan Gregory
September 02, 2022 02:05 PM
The Paris skyline and Eiffel Tower, France

The French company has completed a sale of new shares despite the selloff of biotech stocks

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

ABBs-Block TradesFrance
AG
Aidan Gregory
Gift this article